• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G141
Device Problem Pacing Problem (1439)
Patient Problems Bradycardia (1751); Cardiac Enzyme Elevation (1838); Fall (1848); Syncope/Fainting (4411)
Event Date 08/21/2022
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this patient with an implanted cardiac resynchronization therapy defibrillator (crt-d) system passed out and collapsed at church.It was indicated that their heart rate was down to 45 beats per minute.The patient was transported to the hospital.It was noted that the patients enzyme levels were high.The patients wife contacted boston scientific technical services (ts) to inquire if a boston scientific field representative would be coming to the hospital.Ts discussed representative availability and provided guidance to continue to work with the healthcare providers to determine the care plan for the patient.Subsequent information provided by a boston scientific field representative indicated they were not sure what caused the syncope, what actions were taken or what the resolution was for the patient.The crt-d device remains in-service.It was noted that no additional adverse patient effects were reported.
 
Event Description
It was reported that this patient with an implanted cardiac resynchronization therapy defibrillator (crt-d) system passed out and collapsed at church.It was indicated that their heart rate was down to 45 beats per minute.The patient was transported to the hospital.It was noted that the patient's enzyme levels were high.The patients wife contacted boston scientific technical services (ts) to inquire if a boston scientific field representative would be coming to the hospital.Ts discussed representative availability and provided guidance to continue to work with the healthcare providers to determine the care plan for the patient.Subsequent information provided by a boston scientific field representative indicated they were not sure what caused the syncope, what actions were taken or what the resolution was for the patient.The crt-d device remains in-service.It was noted that no additional adverse patient effects were reported.Additional information was received that this crt-d device was subsequently explanted and replaced due to normal battery depletion more than a year after the reported event.The device was returned to boston scientific for analysis.No adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.The device was exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed, and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15370717
MDR Text Key299380740
Report Number2124215-2022-34663
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/26/2017
Device Model NumberG141
Device Catalogue NumberG141
Device Lot Number108579
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 08/22/2022
Initial Date FDA Received09/07/2022
Supplement Dates Manufacturer Received02/15/2024
Supplement Dates FDA Received02/19/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/26/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age79 YR
Patient SexMale
-
-